|
楼主 |
发表于 2008-12-16 13:37:59
|
显示全部楼层
23-9-第九节 抗中性粒细胞胞浆抗体
抗中性粒细胞胞浆抗体(antineutrophil cytoplasmic antibody, ANCA)是一种以中性粒细胞和单核细胞胞浆成分为靶抗原的自身抗体。1982年,Davies等在8例节段性坏死性肾小球肾炎患者血清中首次发现了ANCA。现已发现,ANCA自身抗体谱存在十余种特异性抗体,ANCA对系统性血管炎、炎性肠病和自身免疫性肝病等疾病的诊断与鉴别诊断具有重要意义。ANCA已成为自身免疫病重要的临床常规检测项目(详见第22章)。ANCA是自身免疫性肝病标准诊断谱的最新成员,主要见于自身免疫性肝病中的AIH-Ⅰ型及 PSC患者中,而PBC患者则少见。自身免疫性肝病中出现的ANCA,其免疫荧光染色型为核周型 ANCA(perinuclear ANCA, pANCA)或非典型性AN-CA(atypical ANCA, aANCA或xANCA)。其特异性靶抗原尚未完全清楚,可能是肌动蛋白(actin)或位于核板层(lamina)的某些粒细胞特异性抗原成分,而不同于原发性系统性血管炎患者中ANCA所常对应的特异性靶抗原,如蛋白酶3 ( proteinase 3, PR3)和髓过氧化物酶(myeloperoxidase, MPO)等。, b: M0 O, x; f8 @
0 D2 v) o# O& M' X8 s4 L3 _$ q
一、检测方法 - Z2 [ P2 f4 Y' m
' u5 v/ q* f3 Q w8 q: v. B' a& o2 f
因尚未完全清楚自身免疫性肝病中出现的ANCA所对应的特异性靶抗原,以肝胆损伤等症状为主的自身免疫性肝病患者,常规检测ANCA可只选用间接免疫荧光法,检测结果ANCA阳性免疫荧光染色型多为pANCA或aANCA。
* R4 \, w r$ A3 ]- H8 v" _1 ~ o( G
/ q3 [+ Z/ ~; S0 E+ e t( E 二、临床意义
3 B- N$ j* o3 P [. w4 c* \. t2 _) e* E& a# r
pANCA主要见于自身免疫性肝病中的AIH-Ⅰ型及 PSC患者中,阳性率分别为 65%~92%,29%~88%,而AIH- II型、PBC及其他非自身免疫性肝病患者中则少见。ANCA检测有助于自身免疫性肝病患者的诊断、分型及鉴别诊断,并可用于慢性隐源性肝病的分类。
2 _; w. d9 [0 \
' r1 b: q# ~ BpANCA与AIH-Ⅰ型的疾病活动度(转氨酶和γ-球蛋白水平)相关,ANCA阳性患者的病情常较重。pANCA阳性的PSC患者,合并溃疡性结肠炎(ulcerative colitis, UC)的可能性较大,亦与胆管树受累广度相关,病情往往较重。 6 r9 h7 z3 t. V
(李永哲 )+ Q9 ?; R, S8 _9 O+ R* z/ G, `
: s% M) Q) m, R) o
参考文献, K) f3 n9 C1 c0 }
' J% o) Q! [& W- J; `, f1 [1 h. p 董怡.自身免疫性肝炎是否一独立疾病 .中华风湿病学杂志,1998.2(2):63一64
' c' `( k, }/ R5 ^& R
3 p9 _$ N+ |" u2 G8 D; F! ~( _ 滑立伟,张煊 .临床病例讨论 第 12例一呕血、口干、眼干、粒细胞缺乏 .中华风湿病学杂志,2001.5(4):2“一267 3 A5 B" x6 u# ~; v# ~
( c! c) V3 I, @6 x7 v' M 刘厚饪.重视对自身免疫性肝炎的研究 .肝脏,2000.5(2):65 1 U* x- W2 m {& i, v; A
4 h# v* i6 e8 w5 f. V6 P) i 伍沪生,宋慧,黄彦弘,等 .原发性干燥综合征的肝脏损害.中华风湿病学杂志,2001.5(1):29一31
" o+ {5 D6 X3 W, X# h2 r5 a# C1 _; D5 Q1 y
张福奎,贾继东,王宝恩,等 .45例原发性胆汁性肝硬化的临床特征.中华内科杂志,2002.41(3):163一167
9 p% _( P4 m2 ^' d) M- D
1 K) x5 f0 V5 n2 [ 张煊,林进,唐福林,等 .原发性胆汁性肝硬化的临床及病理分析 .中华风湿病学杂志,2001.5(2):98一101 ' ~( n2 ^6 T M- N
4 N2 T. g" d ?1 o- J
Abuaf N,]ohanet C,chretien P, et al. Characterisation of theLiver Cytosol antigen Type 1 reacting with autoantibodies inchronic active hepatitis. HEpatology,1992. 16:892一898 / H4 X' L) D/ n# c( h" Z8 E6 ?/ |
9 y( N" X- s. }# k/ o! @1 T) q
Albert J. , Czaja, Henry A. Homburger. Autoantibodies in liv-er disease. Gastroenterology, 2001.120:239一249
# @+ ^4 M9 F4 }( }6 a. d3 s7 O) q3 ~ ?% W0 R- m) t0 S1 Z F
Andrae LE,Chan EK,Raska I, et al. Human autoantibody toa novel protein of the nuclear coild body :Immunological Charac-terization and cDNA cloing of p80- coilin. J Exp Med,1991,173:1407一1419
$ [" ~* o# L( [: m& P! v; q7 K( D
& w- J' U4 v9 T. a; u0 ~ Bandin 0,Courvalin JC,Poupon R, et al. Specificity and sen-sitivity of gp210 autoantibodies detected using an enzyme-linkedimmunosorbent assay and a synthetic polypeptide in the diagnosisof primary biliary cirrhosis. HEpatology,1996.23:1020一1024
! C' d- ?( m* T, [! r/ d6 v
- ^8 a7 G H+ K/ D& Y" l Bansi D, Chapman R, Fleming K. Antineutrolphil cytoplas-mic antibodies in chronic liver disease: prevalence, titre, specifici-ty and IgG subclass. J HEpato1,1996. 24:581一586
0 l7 ]+ u% I. _
# s: S/ O% i/ c) U( E Berg PA, Klein R二Antimitochondrial antibodies in primarybiliary cirrhosis and other disorders: definition and clinical rele-vance. Dig Dis,1992.10:248一264
6 ]4 r: T8 ?- ]5 ]7 `: b$ x/ D$ {* n" U
Bluthner M,Schafer C and Schneider, et al. Identification ofmajor epitopes on the Sp100 nuclear PBC autoantigen by thegene-fragment phage-display technology. Autoimmunity, 1999.29:32一42 . E! c" z+ G: i2 K
8 r3 M2 x3 w" r* Q8 w L1 E
Bylund DMchutchison J. Autoimmune liver diseaes. Clin LabMED, 1997, 17: 483一497.
0 A* H9 o( z5 B( F* ]2 b9 F! e6 Z% x6 _/ ^9 ~: n
Cancado ELR, Vilas-Boas LS,Abrantes-lemos CP, et al. Heat serum inactivation as a mandatoryprocedure for antiactin antibody detection in cell culture. HEpa-tology,1996.23:1098一1104
5 Q, J; n: h* }) Z5 O% l' v @; Q" y4 N
Chen M, Shirai M, Czaja AI, et al. Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis. JGastroenterol HEpatol 1998.13:483一489 ! A8 U2 [2 B. p
5 J' Z% z' K! u5 C$ ?. E. @& u Courvalin JC, Worman I{I. Nuclear envelop protein autoanti-bodies in primary biliary cirrhosis. Semin Liver Dis 1997.17:79一90 8 |' P2 ]+ n7 \7 d
7 `! R5 ~/ x- [. R" v0 \1 G4 a6 V
Czaja AJ, Cassani F, Cataleta M, et al. Antinuclear antibodiesand patterns of nuclear immunofluorescence in type 1 autoimmunehepatitis. Dig Dis Sci 1997.42:1688一1696
1 n! P* L3 J0 K1 n: A/ l- W4 j. _+ c! K4 U7 o: m$ G3 S
Czaja AJ, Manns MP, Homburger HA et al. Frequency andsignificance of antibodies to liver/ kidney microsome antibodiestype 1 in adults with chronic active hepatitis. Gastroenterology,1992.103:1290一1295 ) Z* n) b% [: S" y
% `4 w6 F: K& ]: d& O) _& A Czaja幻,Manns MP. The validity and importance of sub-types of autoimmune hepatitis: a point of view. Am J Gastroen-terol 1995. 90:1206一1211
# q/ Z" j5 Y) l7 W, h7 N& O1 n7 h1 @ v5 V
Czaj a川,Ming C,Shirai M, et al. Frequency and significanceof antibodies to histones in autoimmune hepatitis. J HEpatol1995.23:32一38 ( V* Q0 B. w; g4 D
; V& |+ Z `: O4 f
Czaja Aj, Morshed SA, Parveen S, et al. Antibodies to singlestranded and double-stranded DNA in antinuclear antibody posi-tive type 1 autoimmune hepatitis. HEpatologe, 1997. 26: 567一573
5 o9 z: A; r! a7 y1 z% n. ?
4 w& C9 c: o1 x; _$ |- |4 r" ]3 ? Dighiero G, Lymberi P, Monot C et al. Sera with high levelsof anti-smooth muscle and anti-mitochondrial antibodies frequentlybind to cytoskeletal proteins. Clin Exp Immunol 1990.82:52一56
; H% a; f, s5 D A8 W$ o5 k2 }$ J7 i) m2 D
Duclos-Vallee JC, Hajoui O, Yamamoto AM, et al. Comfor-mational epitopes on CYP2D6 are recognized by liver/ kidney mi-crosome antibodies. Gastroenterology,1995.108:470一476
* T' h( d* ]& P; G o6 C4 Y& e' O+ W! K; P! u: v+ M
Durazzo M, Philip T, Van Pelt FNAM, et al. Heterogeneityof Liver-Kidney Microsomal autoantibodies in chronic hepatitis Cand D virus infection. Gastroenterology, 1995.108:455一462
+ J9 h3 f' z0 c5 O8 O* d
" F7 Z$ U* z* x Fusconi M,Cassani F, Zauli D, et al. Anti-actin antibodies: anew test for an old problem. J Immunol Methods, 1990. 130:1一8 6 M8 A& S$ y. c5 f
. |# b% ]2 }# t5 |6 {7 d& l, U Hill C,Roberts-Thompson P,Pollard A,et al. Clinical associ-ations of anti-lamin antibodies. Aust N J Med 1996.26:162一166 8 a* D" k, P4 T: s
8 b- c' O, V# E
Ingrid Wies,Silvia Brunner,Juergen Henninger,et al. Identi-fication of target antigen for SLA/LP autoantibodies in autoim-mune hepatitis. Lancet, 2000.355:1510一1515 . T* {5 V y2 O" C0 t) |( M8 A" z( `
) U6 ]$ Z# F* K% s# ~( P Itoh S, Ichida T, Yoshida T, et al. Autoantibodies against a210 Kda glycoprotein of the nuclear pore complex as a prognosticmarker in patients with primary biliary cirrhosis. J Gastroen-terology HEpatol 1998. 13:257一265 # ~: n' w9 @" Q7 Z$ y# Z4 f0 h7 v
0 ^4 e" y4 U% c
Klein R,Berg PA. Glutathione S-transferase as a major au-toantigen in anti-SLA-positive autoimmune hepatitis(letter).Gas-troenterology,1999.116:1015一1016
& ~ [& g( F! X- n9 ~* M" m: t
; @7 {1 ?) I# `: T# Z( D Konstantinov K,von Mikeez A,Buchwald D, et al. Autoanti-bodies to nuclear envelop antigens in chronic fatigue syndrome. JClin Invest 1996.98:1888一1896 5 {% l" @# c: @ r1 L0 L9 M
' b% Y8 d/ L$ s* a$ ?1 L# ] LaBrecque DR, Phillips MJP, lppolito LA, et al. Antineu-trolphil cytoplasmic antibody and chronic liver disease(abstr ).HEpatology, 1999.30:428A : W$ ]' j1 a, _- H9 ~6 ]% U: @
, t: W, n: o/ D7 W# K; { Lenzi M, Manotti P, Muratori L, et al. Liver Cytosolic 1antigen- antibody system in type 2 autoimmune hepatitis and hep-atitis C virus infection. Gut, 1995. 36:749一754
. V3 X7 `8 l; c
8 x! q1 _: \4 v, y Lin F, Noyer CM, Ye Q, et al. Autoantibodies from patientswith primary biliary cirrhosis recognize a region within the nucleo-plasmic domain of inner nuclear membrane protein LBR. HEpa-tology,1996. 23:57一61 ) t: _% T: [7 y( `1 {4 k! f
2 Y& }# O4 v* c" z* c
Ma Y, Peakman M, Lobo-Yeo A, et al. Differences in im-mune recognition of cytochrome P450D6 by liver kindney micro-somal(LKM) antibody in autoimmune hepatitis and chronic hep-atitis C virus infection. Clin Exp Immuno1,1994. 97:94一99
0 F+ P7 R8 L* S; E1 y4 h2 U% x: O0 \) g0 D8 z) _
McFarlane IG. The relationship between autoimmune mark-ers and different clinical syndromes in autoimmune hepatitis. Gut,1998.42:599一602 $ \/ r9 z' S: R& F0 e; a& U
+ F0 x8 P, H. A8 C- ~6 o3 @
McHugh NJ,James IE, Kairburn K, et al. Autoantibodies tomitochondria) and centromere antigens in primary biliary cirrhosisand systeemic sclerosis. Clin Exp Immuno1,1990. 81:244一249 9 L) `3 v6 E0 _) i1 J
# { r3 [9 q' ~0 n5 f4 ?) v
Michael P. Manna and Christian P. Strassburg. Autoimmunehepatitis: clinical challenges. Gastroenterology,2001.120:1502-1517
- M2 q1 w$ g4 B* A, U# D' W" X9 g5 d# @ t7 z" X
Miyakawa H, Kikuchi K, Jong-Hon K, et al. High sensitivi-ty of a novel ELISA for anti-M2 in primary biliary cirrhosis. JGastroenterol, 2001.36:33一38
l) J q0 F2 w b j ?, L4 K9 b4 P3 w
Muratori L,Cataleta P,Muratori P, et al. Liver/ kidney mi-crosomal antibody type land liver cytosol antibody type 1 in type2 autoimmune hepatitis. Gut, 1999. 42:721一726
" Z) A$ h h1 m) Z+ K" Y5 x1 o9 W; p8 E- Q" Y
Onouchi H, Muro Y, Tomita Y. Clinical features and tgGsubclass distribution of anti-p80 coilin antibodies. J Autoimmun,1999.13:225一232 ^) O, i* T+ u/ i! _2 M4 A( w
+ m0 f2 }- T: `3 o, F' j$ y$ M Orth T, Gerken, Zum M, et al. Actin is a target of antineu-trolphil cytoplasmic antibodies (ANCA) in autoimmune hepatitistype 1. J HEpatolalogy, 1996.24:581一586 5 C6 F( b/ U" `" p+ Q& ^; M
V9 i! Y' z K/ S
Senecal JL, Rauch J , Grodzicky T, et al. Strong association ofautoantibodies to human nuclearlant antibodies in systemic lupuslamin B1 with lupus anticoagu-erythematosus. Arthritis Rheum1999.42:1347一53 ! n) o6 W5 d9 J; u2 r
' t& \9 F5 V' O% q' U9 M
Sternsdorf T, Guldner HH, Szostecki C, et al. Two nucleardotassociated proteins, PMLand sp100, are often co-autoim-munnogenic in patients with primary biliary cirrhosis. Scand J Im-muno1,1995. 42:257一268
) }/ ?0 T- L1 R1 S, {2 E8 ?
: s6 @0 O/ Z: ~5 T Szostecki C,Guldner HH and Will H. Autoantibodies against"nuclear dots" in primary biliary cirrhosis. Seminars in Liver Dis-ease, 1997.17:71一78 & E0 L: ~! o) g1 n' U( G
$ s3 c2 g3 o& Z/ `8 h
Targan RS, landers C, Vidrich A, et al. High-titer antineu-trolphil cytoplasmic antibodies in type 1 autoimmune hepatitis.Gastroenterology,1995.108:1159一1166
7 S+ y; W1 K! t9 f" E% U1 X6 D
$ z8 A0 V# Z* L* `# i1 s* `! p reichel U, Gerken G, Rossol S, et al. Autoantibodies a-gainst the human asialoglycoprotein receptor: effects of therapy inautoimmune and virus-induced chronic active hepatitis. J HEpatol,1993.19:55一63
! D y) E4 M0 }4 t5 ^1 p3 f* I
/ W3 y! s: G$ ] Treichel U,Porallat,Hess G, et al. Autoantibodies to humanasialoglycoprotein receptor in autoimmune-type chronic hepatitis.HEpatology,1990.11:606一612 3 q7 r) G/ s# D0 B
9 q- H8 f9 a% {1 ]+ M/ f' r Wesierska-Gadek J, Grimm R, Hitchman E, et al. Membersof the Glutathione S-transferase gene family are antigens in au-toimmune hepatitis. Gastroenterology,1998. 114:329一335 www.ikang.org
% x0 f& E }9 p% v5 y$ l7 H. ]8 @6 g9 x3 {% m1 a1 t
WesierskaGadek J, Hohenuer H, Hitchman E, et al. Au-toantibodies from patients with primary biliary cirrhosis preferen-tially react with the amino-terminal domain of nuclear pore com-plex glycoprotein gp210. J Exp Med 1995.182(4):1159一1162 ) Z$ D V# k; y# e5 f- f/ }
3 H1 u5 \* ], i3 V# m+ J Wesierska-Gadek J,Hohenuer H, Hitchman E, et al. Autoan-tibodies against nucleoporin p62 consitute a novel marker of pri-mary biliary cirrhosis. Gastroenterology 1996. 110:840一847
3 V. n v% v( b% N
: C( S5 \% ^6 g) M Zauli D, Ghetti S, Grassi A, et al. Anti- neutrolphil cytoplas-mic antibodies in type 1 and type 2 autoimmune hepatitis. HEpa-tology, 1997.25:1105一1107 |
|